Paris, France and Camberley, UK – 29 April 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, provides an update on its polymerase chain reaction (PCR) test for COVID-19, developed by Primerdesign, the Company’s molecular diagnostics division based in the UK. http://novacyt.com/wp-content/uploads/2020/04/Novacyt-COVID-19-test-update-and-notification-of-final-results-ENGLISH-29.04.2020.pdf
Visit PageCategory: NOVAPREP®
Contrat avec le Ministère de la Santé et des Affaires Sociales britannique pour la fourniture de tests COVID-19
Paris, France et Camberley, Royaume-Uni – 27 avril 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, annonce avoir signé un contrat d’approvisionnement avec le Ministère de la Santé et des Affaires Sociales britannique (Department of Health and Social Care – DHSC) pour son test COVID-19 (CE IVD) d’amplification
Visit PageContract with UK Department of Health and Social Care for supply of COVID-19 tests
Paris, France and Camberley, UK – 27 April 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces it has signed a supply contract with the UK Department of Health and Social Care (DHSC) for its COVID-19 (CE IVD) polymerase chain reaction (PCR) test, developed by Primerdesign, the Company’s molecular
Visit Page